CAE reports fourth quarter and full-year financial results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CAE reports fourth quarter and full-year financial results for fiscal year 2013

MONTREAL, CANADA--(Marketwired - May 16, 2013) - (NYSE:CAE)(TSX:CAE) - CAE today reported financial results for the fourth quarter and full-year ended March 31, 2013. Net income attributable to equity holders was $43.8 million ($0.17 per share) this quarter, compared to $53.2 million ($0.21 per share) last year. Net income attributable to equity holders for the year was $139.4 million ($0.54 per share), compared to $180.3 million ($0.70 per share) last year. All financial information is in Canadian dollars.

Excluding $10.1 million (after-tax) of restructuring, integration and acquisition costs this quarter, net income attributable to equity holders was $53.9 million ($0.21 per share). On the same basis, it was $190.7 million ($0.74 per share) for the year.

Revenue for the quarter was $587.9 million, 16% higher than $506.7 million in the fourth quarter last year. For the full year, revenue was $2,104.5 million, up 16% from $1,821.2 million last year.

"Our results for the quarter and the year reflected our integration of new businesses and restructuring of Civil and Military operations," said Marc Parent, CAE's President and Chief Executive Officer. "Backlog exceeded $4 billion for the first time in CAE's history, with a high proportion involving recurring services. In Civil Products, we had a strong finish to the year, meeting our mid-30s full-flight simulator order outlook. With continued high levels of aircraft deliveries, we expect strong demand for civil full-flight simulators again in fiscal 2014. In Civil Training, the integration of Oxford progressed well, with cost synergies on target. In Military, we booked orders involving enduring aircraft programs, which gives us confidence in sustaining our business in a still-challenging environment. New Core Markets delivered on our financial goals and we expect our investments in new products and expanded sales capabilities to bear fruit in the period ahead."

Summary of consolidated results

(amounts in millions, except operating margins) FY2013 FY2012 Q4-2013 Q3-2013 Q2-2013 Q1-2013 Q4-2012
Revenue $ 2,104.5 1,821.2 587.9 522.1 514.4 480.1 506.7
Operating profit (1) $ 245.7 302.1 71.6 62.4 66.9 44.8 88.7
As a % of revenue % 11.7 16.6 12.2 12.0 13.0 9.3 17.5
Net Income $ 142.4 182.0 46.4 37.5 36.8 21.7 53.7
Net income attributable to the equity holders of the Company $ 139.4 180.3 43.8 37.8 36.5 21.3 53.2
Backlog (2) $ 4,091.9 3,724.2 4,091.9 3,833.0 3,909.1 3,894.5 3,724.2

Civil segments

Revenue for our combined Civil segments increased 54% in the fourth quarter to $331.6 million compared to $215.4 million last year. Fourth quarter operating profit was $54.1 million (16.3% of revenue) compared to $44.3 million (20.6% of revenue) last year.

Annual revenue was $1,158.0 million, up 38% from $840.9 million last year. Annual operating profit was $195.1 million (16.8% of revenue) compared to $173.8 million (20.7% of revenue) last year.

We received 10 full-flight simulator (FFS) orders in the fourth quarter to conclude the year with 35 in total. We also obtained training services contracts expected to generate $456.7 million in future revenue, including long-term training services contracts with LAN, TAM, Turkish Airlines, Virgin Atlantic and Brussels Airlines. We also renewed a long-term contract with GE Capital Aviation Services for crew sourcing and we signed an agreement with Ryanair for training and recruitment services.

We received $607.5 million in combined civil segment orders this quarter representing a book-to-sales ratio of 1.83x. The ratio for the trailing 12 months was 1.18x.

Training & Services/Civil (TS/C)

(amounts in millions except operating margins, RSEU (3) and FFSs deployed) FY2013 FY2012 Q4-2013 Q3-2013 Q2-2013 Q1-2013 Q4-2012
Revenue $ 755.6 498.4 201.8 193.8 189.1 170.9 132.3
Segment operating income $ 121.5 122.2 31.8 29.1 27.3 33.3 30.3
Operating margins % 16.1 24.5 15.8 15.0 14.4 19.5 22.9
Backlog $ 1,602.2 1,183.4 1,602.2 1,345.8 1,360.9 1,400.0 1,183.4
RSEU (3) 181 139 187 186 187 164 142
FFSs deployed 227 171 227 222 218 216 171

Simulation Products/Civil (SP/C)

(amounts in millions except operating margins) FY2013 FY2012 Q4-2013 Q3-2013 Q2-2013 Q1-2013 Q4-2012
Revenue $ 402.4 342.5 129.8 93.4 98.9 80.3 83.1
Segment operating income $ 73.6 51.6 22.3 18.0 18.9 14.4 14.0
Operating margins % 18.3 15.1 17.2 19.3 19.1 17.9 16.8
Backlog $ 383.2 351.6 383.2 361.2 385.2 361.9 351.6

Military segments

Revenue for our combined Military segments decreased 15% in the fourth quarter to $227.3 million compared to $267.1 million last year. For the year, revenue was $834.4 million, down 7% from $897.3 million last year.

Combined Military operating income was $29.4 million (12.9% of revenue) for the quarter, compared to $45.6 million (17.1% of revenue) last year. For the full year, operating income was $113.1 million (13.6% of revenue), compared to $142.1 million (15.8% of revenue) last year.

We booked orders in our Simulation Products Military segment during the quarter involving enduring aircraft types like the MH-60 Seahawk helicopter and the C-130J Hercules transport aircraft. These orders comprised simulator products and updates in support of the U.S. Navy and Air Force, the Royal Australian Navy, and the Israeli Air Force. We were also awarded contracts in our Training and Services Military segment to provide a range of maintenance and support services for customers including NATO, the U.S. Air Force, the German Armed Forces, and the Taiwan Air Force. As part of the U.S. Air Force's KC-135 Aircrew Training Systems program, for which CAE is the prime contractor, we were awarded an additional contract to provide operations and maintenance support involving the aerial refueling aircraft's boom operator trainers.

We received $215.9 million in combined military segment orders this quarter, representing a book-to-sales ratio of 0.95x. The ratio for the trailing 12 months was 0.92x.

Simulation Products/Military (SP/M)

(amounts in millions except operating margins) FY2013 FY2012 Q4-2013 Q3-2013 Q2-2013 Q1-2013 Q4-2012
Revenue $ 561.6 619.2 154.9 140.5 130.8 135.4 195.6
Segment operating income $ 77.9 101.2 19.2 18.3 20.9 19.5 34.6
Operating margins % 13.9 16.3 12.4 13.0 16.0 14.4 17.7
Backlog $ 685.0 786.0 685.0 728.9 723.1 755.6 786.0

Training & Services /Military (TS/M)

(amounts in millions except operating margins) FY2013 FY2012 Q4-2013 Q3-2013 Q2-2013 Q1-2013 Q4-2012
Revenue $ 272.8 278.1 72.4 65.7 67.3 67.4 71.5
Segment operating income $ 35.2 40.9 10.2 8.7 7.4 8.9 11.0
Operating margins % 12.9 14.7 14.1 13.2 11.0 13.2 15.4
Backlog $ 1,421.5 1,403.2 1,421.5 1,397.1 1,439.9 1,377.0 1,403.2

New Core Markets

Revenue in New Core Markets was $29.0 million for the quarter, up 20% from $24.2 million last year. Operating income was $1.8 million for the quarter, compared to negative $1.2 million last year. Annual revenue was $112.1 million up 35% from $83.0 million last year and operating income was $6.4 million, compared to negative $13.8 million last year.

In CAE Healthcare, we continued to make good progress penetrating global markets with sales of our surgical, patient, and ultrasound simulators, as well as centre management systems to customers in Canada, the U.S., Australia, India and Saudi Arabia.

In CAE Mining, we sold our mine planning software to customers in China and Russia and our new stratigraphic modeling software to customers in South Africa and Chile. We also received a contract to implement a complete suite of geological data management, resource modeling and mine planning software to a gold mining company operating long life projects in Vietnam and Malaysia.

New Core Markets (NCM)

(amounts in millions) FY2013 FY2012 Q4-2013 Q3-2013 Q2-2013 Q1-2013 Q4-2012
Revenue $ 112.1 83.0 29.0 28.7 28.3 26.1 24.2
Segment operating income (loss) $ 6.4 (13.8 ) 1.8 1.7 2.2 0.7 (1.2 )
Operating margins % 5.7 - 6.2 5.9 7.8 2.7 -

Additional financial highlights

Income taxes this quarter were $7.0 million representing an effective tax rate of 13%, compared to 26% last year. The decrease in the effective tax rate from the fourth quarter of fiscal 2012 was mainly due to the settlement of tax audits as well as the change in the mix of income from various jurisdictions. Excluding the effect of the one - time items in the quarter, the income tax expense would have been $11.5 million. The impact of these one-time items represents $0.02 on earnings per share.

Free cash flow (4) was positive $108.6 million this quarter. Our free cash flow is generally higher in the second half of the fiscal year, a trend that is expected to continue in fiscal 2014. The increase in free cash flow compared to the fourth quarter last year results mainly from favorable changes in non-cash working capital.

Capital expenditures totalled $32.4 million this quarter, including $29.5 million for growth and $2.9 million for maintenance.

Net debt (5) was $916.8 million as at March 31, 2013, compared with $965.4 million as at December 31, 2012.

CAE will pay a dividend of $0.05 per share effective June 28, 2013 to shareholders of record at the close of business on June 14, 2013.

Additional information

You will find a more detailed discussion of our results by segment in the Management's Discussion and Analysis

(MD&A) as well as in our consolidated interim financial statements which are posted on our website at www.cae.com/investors .

CAE's unaudited consolidated interim financial statements and management's discussion and analysis for the quarter ended March 31, 2013 have been filed with the Canadian securities commissions and are available on our website (www.cae.com) and on SEDAR (www.sedar.com) . They have also been filed with the U.S. Securities and Exchange Commission and are available on their website ( www.sec.gov ).

Conference call Q4 and full-year FY2013

CAE will host a conference call focusing on fiscal year 2013 fourth quarter and full-year financial results today at 1:00 p.m. ET. The call is intended for analysts, institutional investors and the media. Participants can listen to the conference by dialling + 1 877 586 3392 or +1 416 981 9024. The conference call will also be audio webcast live for the public at www.cae.com .

CAE is a global leader in modeling, simulation and training for civil aviation and defence. The company employs approximately 8,000 people at more than 100 sites and training locations in approximately 30 countries. CAE offers civil aviation, military, and helicopter training services in more than 45 locations worldwide and trains approximately 100,000 crewmembers yearly. In addition, the CAE Oxford Aviation Academy offers training to aspiring pilot cadets in 11 CAE-operated flight schools. CAE's business is diversified, ranging from the sale of simulation products to providing comprehensive services such as training and aviation services, integrated enterprise solutions, in-service support and crew sourcing. The company applies simulation expertise and operational experience to help customers enhance safety, improve efficiency, maintain readiness and solve challenging problems. CAE is leveraging its simulation capabilities in new markets such as healthcare and mining. www.cae.com

You will find more information about the risks and uncertainties associated with our business in the MD&A section of our annual report and annual information form for the year ended March 31, 2012. These documents have been filed with the Canadian securities commissions and are available on our website ( www.cae.com ), on SEDAR (www.sedar.com) and a free copy is available upon request to CAE. They have also been filed with the U.S. Securities and Exchange Commission under Form 40-F and are available on EDGAR ( www.sec.gov ). The forward-looking statements contained in this news release represent our expectations as of May 16, 2013 and, accordingly, are subject to change after this date. We do not update or revise forward-looking information even if new information becomes available unless legislation requires us to do so. You should not place undue reliance on forward-looking statements.

Notes

(1) Operating profit is non-GAAP measure that shows us how we have performed before the effects of certain financing decisions and tax structures. We track operating profit because we believe it makes it easier to compare our performance with previous periods, and with companies and industries that do not have the same capital structure or tax laws.
(2) Backlog is a non-GAAP measure that represents the expected value of orders we have received but have not yet executed.
(3) Revenue simulator equivalent unit (RSEU) is a financial measure we use to show the total average number of FFSs available to generate revenue during the period.
(4) Free cash flow is a non-GAAP measure that shows us how much cash we have available to build the business, repay debt and meet ongoing financial obligations. We use it as an indicator of our financial strength and liquidity. We calculate it by taking the net cash generated by our continuing operating activities, subtracting maintenance capital expenditures, other assets not related to growth and dividends paid and adding proceeds from disposal of property, plant and equipment.
(5) Net debt is a non-GAAP measure we use to monitor how much debt we have after taking into account liquid assets such as cash and cash equivalents. We use it as an indicator of our overall financial position, and calculate it by taking our total long-term debt, including the current portion of long-term debt, and subtracting cash and cash equivalents.
Consolidated Statement of Financial Position
(Unaudited)
As at March 31
(amounts in millions of Canadian dollars) 2013 2012
Assets
Cash and cash equivalents $ 293.2 $ 287.3
Accounts receivable 399.5 308.4
Contracts in progress : assets 247.3 245.8
Inventories 186.6 153.1
Prepayments 56.3 47.7
Income taxes recoverable 141.9 95.5
Derivative financial assets 9.0 10.3
Total current assets $ 1,333.8 $ 1,148.1
Property, plant and equipment 1,498.6 1,293.7
Intangible assets 799.2 533.2
Deferred tax assets 39.4 24.1
Derivative financial assets 6.4 7.2
Other assets 201.3 177.4
Total assets $ 3,878.7 $ 3,183.7
Liabilities and equity
Accounts payable and accrued liabilities $ 695.5 $ 597.6
Provisions 49.2 21.6
Income taxes payable 13.7 10.9
Contracts in progress : liabilities 117.9 104.6
Current portion of long-term debt 113.0 136.0
Derivative financial liabilities 13.5 12.7
Total current liabilities $ 1,002.8 $ 883.4
Provisions 8.3 6.0
Long-term debt 1,097.0 685.6
Royalty obligations 160.6 161.6
Employee benefits obligations 136.1 114.2
Deferred gains and other non-current liabilities 194.6 186.0
Deferred tax liabilities 131.6 91.8
Derivative financial liabilities 13.2 12.9
Total liabilities $ 2,744.2 $ 2,141.5
Equity
Share capital $ 471.7 $ 454.5
Contributed surplus 21.9 19.2
Accumulated other comprehensive loss (16.6 ) (9.8 )
Retained earnings 625.7 558.0
Equity attributable to equity holders of the Company $ 1,102.7 $ 1,021.9
Non-controlling interests 31.8 20.3
Total equity $ 1,134.5 $ 1,042.2
Total liabilities and equity $ 3,878.7 $ 3,183.7
Consolidated Income Statement
(Unaudited)
(amounts in millions of Canadian dollars, Three months ended March 31 Twelve months ended March 31
except per share amounts) 2013 2012 2013 2012
Revenue $ 587.9 $ 506.7 $ 2,104.5 $ 1,821.2
Cost of sales 420.5 336.6 1,482.8 1,221.1
Gross profit $ 167.4 $ 170.1 $ 621.7 $ 600.1
Research and development expenses 18.1 15.2 60.6 62.8
Selling, general and administrative expenses 66.9 71.8 269.9 256.4
Other gains - net (2.9 ) (5.6 ) (23.4 ) (21.2 )
Restructuring, integration and acquisition costs 13.7 - 68.9 -
Operating profit $ 71.6 $ 88.7 $ 245.7 $ 302.1
Finance income (1.5 ) (1.5 ) (7.3 ) (6.6 )
Finance expense 19.7 18.1 75.5 69.2
Finance expense - net $ 18.2 $ 16.6 $ 68.2 $ 62.6
Earnings before income taxes $ 53.4 $ 72.1 $ 177.5 $ 239.5
Income tax expense 7.0 18.4 35.1 57.5
Net income $ 46.4 $ 53.7 $ 142.4 $ 182.0
Attributable to:
Equity holders of the Company $ 43.8 $ 53.2 $ 139.4 $ 180.3
Non-controlling interests 2.6 0.5 3.0 1.7
$ 46.4 $ 53.7 $ 142.4 $ 182.0
Earnings per share from continuing operations attributable to equity holders of the Company
Basic and diluted $ 0.17 $ 0.21 $ 0.54 $ 0.70
Consolidated Statement of Comprehensive Income
(Unaudited) Three months ended March 31 Twelve months ended March 31
(amounts in millions of Canadian dollars) 2013 2012 2013 2012
Net income $ 46.4 $ 53.7 $ 142.4 $ 182.0
Foreign currency translation
Net currency translation difference on the translation of financial statements of foreign operations $ 12.8 $ (5.1 ) $ 10.6 $ 13.5
Net (losses) gains on certain long-term debt denominated in foreign currency and designated as hedges of net investments in foreign operations (8.6 ) 3.4 (8.8 ) (3.9 )
Income taxes 1.2 (0.6 ) 0.7 0.8
$ 5.4 $ (2.3 ) $ 2.5 $ 10.4
Net changes in cash flow hedges
Effective portion of changes in fair value of cash flow hedges $ (5.0 ) $ 6.1 $ (2.5 ) $ (8.7 )
Reclassifications to net income or to the related non financial assets or liabilities (1.1 ) (4.5 ) (10.2 ) (4.7 )
Income taxes 1.6 (0.2 ) 3.5 3.1
$ (4.5 ) $ 1.4 $ (9.2 ) $ (10.3 )
Defined benefit plan actuarial losses
Defined benefit plan actuarial losses $ (10.1 ) $ (22.6 ) $ (30.8 ) $ (64.9 )
Income taxes 2.8 5.7 8.3 17.4
$ (7.3 ) $ (16.9 ) $ (22.5 ) $ (47.5 )
Other comprehensive loss $ (6.4 ) $ (17.8 ) $ (29.2 ) $ (47.4 )
Total comprehensive income $ 40.0 $ 35.9 $ 113.2 $ 134.6
Attributable to:
Equity holders of the Company $ 37.4 $ 35.4 $ 110.1 $ 132.8
Non-controlling interests 2.6 0.5 3.1 1.8
$ 40.0 $ 35.9 $ 113.2 $ 134.6
Consolidated Statement of Changes in Equity
(Unaudited) Attributable to equity holders of the Company
Year ended March 31, 2013 (amounts in millions of Canadian dollars, except number of shares) Number of shares Common shares Stated value Contributed surplus Accumulated other comprehensive loss Retained earnings Total Non-controlling interests Total equity
Balances, beginning of year 258,266,295 $ 454.5 $ 19.2 $ (9.8 ) $ 558.0 $ 1,021.9 $ 20.3 $ 1,042.2
Net income - - - - 139.4 139.4 3.0 142.4
Other comprehensive income (loss):
Foreign currency translation - - - 2.4 - 2.4 0.1 2.5
Net changes in cash flow hedges - - - (9.2 ) - (9.2 ) - (9.2 )
Defined benefit plan actuarial losses - - - - (22.5 ) (22.5 ) - (22.5 )
Total comprehensive income - $ - $ - $ (6.8 ) $ 116.9 $ 110.1 $ 3.1 $ 113.2
Stock options exercised 482,250 3.9 - - - 3.9 - 3.9
Optional cash purchase 1,683 - - - - - - -
Stock dividends 1,228,831 12.1 - - (12.1 ) - - -
Transfer upon exercise of stock options - 1.2 (1.2 ) - - - - -
Share-based payments - - 3.9 - - 3.9 - 3.9
Additions to non-controlling interests - - - - - - 8.4 8.4
Dividends - - - - (37.1 ) (37.1 ) - (37.1 )
Balances, end of year 259,979,059 $ 471.7 $ 21.9 $ (16.6 ) $ 625.7 $ 1,102.7 $ 31.8 $ 1,134.5
(Unaudited) Attributable to equity holders of the Company
Year ended March 31, 2012 (amounts in millions of Canadian dollars, except number of shares) Number of shares Common shares Stated value Contributed surplus Accumulated other comprehensive loss Retained earnings Total Non- controlling interests Total equity
Balances, beginning of year 256,964,756 $ 440.7 $ 17.1 $ (9.8 ) $ 466.4 $ 914.4 $ 18.5 $ 932.9
Net income - - - - 180.3 180.3 1.7 182.0
Other comprehensive income (loss):
Foreign currency translation - - - 10.3 - 10.3 0.1 10.4
Net changes in cash flow hedges - - - (10.3 ) - (10.3 ) - (10.3 )
Defined benefit plan actuarial losses - - - - (47.5 ) (47.5 ) - (47.5 )
Total comprehensive income - $ - $ - $ - $ 132.8 $ 132.8 $ 1.8 $ 134.6
Stock options exercised 538,600 4.4 - - - 4.4 - 4.4
Optional cash purchase 898 - - - - - - -
Stock dividends 762,041 7.8 - - (7.8 ) - - -
Transfer upon exercise of stock options - 1.6 (1.6 ) - - - - -
Share-based payments - - 3.7 - - 3.7 - 3.7
Dividends - - - - (33.4 ) (33.4 ) - (33.4 )
Balances, end of year 258,266,295 $ 454.5 $ 19.2 $ (9.8 ) $ 558.0 $ 1,021.9 $ 20.3 $ 1,042.2
The total retained earnings and accumulated other comprehensive loss for the year ended March 31, 2013 was $609.1 million (2012 - $548.2 million).
Consolidated Statement of Cash Flows
(Unaudited)
Years ended March 31
(amounts in millions of Canadian dollars) 2013 2012
Operating activities
Net income $ 142.4 $ 182.0
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation of property, plant and equipment 107.6 92.3
Amortization of intangible and other assets 49.7 33.5
Financing cost amortization 1.8 1.6
Deferred income taxes 28.1 36.4
Investment tax credits (22.6 ) (14.5 )
Share-based compensation (4.2 ) 4.7
Defined benefit pension plans (9.3 ) (13.1 )
Amortization of other non-current liabilities (15.6 ) (12.0 )
Other (12.1 ) (5.3 )
Changes in non-cash working capital (61.7 ) (71.7 )
Net cash provided by operating activities $ 204.1 $ 233.9
Investing activities
Business combinations, net of cash and cash equivalents acquired $ (285.3 ) $ (126.0 )
Joint ventures, net of cash and cash equivalents acquired (0.7 ) (27.6 )
Capital expenditures for property, plant and equipment (155.8 ) (165.7 )
Proceeds from disposal of property, plant and equipment 8.9 34.4
Capitalized development costs (49.6 ) (42.8 )
Enterprise resource planning (ERP) and other software (19.4 ) (17.3 )
Other (3.0 ) 5.0
Net cash used in investing activities $ (504.9 ) $ (340.0 )
Financing activities
Net borrowing under revolving unsecured credit facilities $ 54.0 $ 14.2
Net effect of current financial assets program (37.1 ) 4.9
Proceeds from long-term debt, net of transaction costs 740.4 195.0
Repayment of long-term debt (380.2 ) (36.1 )
Repayment of finance lease (36.3 ) (32.8 )
Dividends paid (37.1 ) (33.4 )
Common stock issuance 3.9 4.4
Other (0.9 ) (0.7 )
Net cash provided by financing activities $ 306.7 $ 115.5
Effect of foreign exchange rate changes on cash and cash equivalents $ - $ 1.5
Net increase in cash and cash equivalents $ 5.9 $ 10.9
Cash and cash equivalents, beginning of year 287.3 276.4
Cash and cash equivalents, end of year $ 293.2 $ 287.3
Supplemental information:
Dividends received $ 2.4 $ 4.7
Interest paid 53.6 49.4
Interest received 5.0 4.7
Income taxes paid 26.5 26.9
Investor relations: Andrew Arnovitz, Vice President Investor Relations and Strategy (514) 734-5760 andrew.arnovitz@cae.com Media: Nathalie Bourque, Vice President Public Affairs and Global Communications (514) 734-5788 nathalie.bourque@cae.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 146

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Heights Wellness Retreat: A Bold Step Towards Holistic Wellness

Updated Category News Views 227

Heights Wellness Retreat: A New Era of Wellness In a landmark announcement during their annual summit, Massage Heights unveiled a significant transformation that redefines their brand identity. The brand, known for its commitment to wellness over the past two decades, will now operate under the name Heights Wellness Retreat. This evolution is more than just a new name; it...

Continue Reading
GeneDx Strengthens Leadership with New COO Appointment

Updated Category News Views 168

GeneDx Welcomes Bryan Dechairo as Chief Operating Officer GeneDx (NASDAQ: WGS) has made headlines with the appointment of Bryan Dechairo as its new Chief Operating Officer. This strategic decision aims to enhance operations and drive the company’s next phase of growth. Enhancing Operations for Future Success As COO, Dechairo will oversee critical areas including Product...

Continue Reading
FreightCar America to Share Q1 2025 Financial Results Soon

Updated Category News Views 130

FreightCar America Prepares for Q1 2025 Earnings Announcement FreightCar America, Inc. (NASDAQ: RAIL), a prominent player in the manufacturing of railroad freight cars, is gearing up to release its financial results for the first quarter of 2025. This important announcement is scheduled for after the market closes on a Monday, allowing investors and stakeholders to digest...

Continue Reading
Empowering Veterans: United Food Group's New Initiative

Updated Category News Views 129

United Food Group Unveils New Employment Initiative United Food Group, a noted developer and manufacturer of coffee equipment, powdered condiments, and beverages, has announced an innovative employment initiative designed to support wounded veterans and first responders. This program not only aims to empower these individuals but also provides them with specialized...

Continue Reading
US Futures Gain on Peace Talk Hopes Amid Market Developments

Updated Category News Views 206

U.S. Stock Futures Trend Upward U.S. stock futures saw an increase following the extended weekend, coming off a mixed trading day last Friday. The day off for Presidents Day allowed investors to reassess their positions. As a result, all four major indices posted gains in premarket trading. Investor Focus on Macro Conditions In today's trading, investors will closely...

Continue Reading